Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2012; 18(29): 3849-3861
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3849
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3849
Figure 4 Methyl-CpG binding domain proteins expression and enrichment in fragment of promoter-associated CpG island.
A: Expression methyl-CpG binding domain proteins (MBPs) in hilar cholangiocarcinoma. Compared to control, 2.9-fold increase of methyl-CpG-binding domain protein (MBD)2 was found while no difference of MBD1 and Mecp2 were detected; B: Chromatin immunoprecipitation (ChIP)-polymerase chain reaction analysis showed selective enrichment of MBD2 at region of CpG island; C: Correlation between MBD2 enrichment and different frequency of CpG island methylation. Remarkable difference was observed between super-/hyper-methylation and stand-/hypo-methylation group (aP < 0.05, bP < 0.01 vs control). GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Chen YJ, Luo J, Yang GY, Yang K, Wen SQ, Zou SQ. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma. World J Gastroenterol 2012; 18(29): 3849-3861
- URL: https://www.wjgnet.com/1007-9327/full/v18/i29/3849.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i29.3849